HomeUSACure Opens XSeed Award Applications To Support Underfunded and Underrepresented Life Sciences...

Cure Opens XSeed Award Applications To Support Underfunded and Underrepresented Life Sciences Startups

Cure

Cure, a healthcare innovation campus in New York City founded and supported by healthcare investment firm Deerfield Management, has opened applications to the XSeed Award.

XSeed Award is an annual competitive program supporting traditionally underfunded and underrepresented minority- and women-led life science and healthcare startups working on drug development in New York City.

In 2024, two winning teams will become eligible to receive up to $250k each. They also will join the Cure ecosystem with their fellow awardees to receive entrepreneurship mentoring and networking designed to help them move promising translational research to the marketplace and commercial success. In addition to advancing their research, the 2024 cohort of X-Seed Award winners will enhance their entrepreneurial skills, networks and visibility via the Cure ecosystem. Graduates of each cohort will then serve as mentors and coaches for future cohorts, further strengthening the entrepreneurial community in New York City.

The deadline for XSeed Award application submissions is May 31, 2024, and virtual finalist presentations will be June 28, 2024. The program will announce winners on Sept. 2, 2024, and they will receive honors at an official ceremony at Cure in October 2024. 

Founded by James E. Flynn, and led by Seema Kumar, CEO, Cure is a healthcare innovation campus in the heart of New York City that features laboratory and business facilities, a collaboration residency, office space and premium event venues, including an education center, conference center, and iconic rooftop facility, as well as tools, mentoring, networking, and other assistance to members of its ecosystem. It houses on-campus startup and established companies. Residents regularly create synergies and collaborative partnerships with peer organizations across the spectrum of healthcare, from academic or private to non-profit or government, and focus on diagnostic, device, drug or vaccine discovery, development and production as well as care delivery and public health. Cure also offers event programming focused on critical health topics.

FinSMEs

11/04/2024